GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Neurogene NGNE · USD

Health Care · US listing · 🇺🇸 United States

Compare

26.00

+2.73%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Neurogene

Our reporting

Next results

12 Nov 2026

Due on 12 Nov 2026. Analysts expect earnings of -1.49 a share.

Past results

Reported against what analysts expected

11 Aug 202610 Aug 202612 May 20268 May 202624 Mar 202614 Nov 2025
Earnings per share-1.53-1.05-1.39-1.08-1.12-0.99
Forecast-1.42-1.39-1.30-1.35-1.24-1.26

Key events

  1. 19 Dec 20234-to-1 reverse split
  2. 25 Sept 20235-to-1 reverse split
  3. 7 Mar 2014Listed

Neurogene in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.